These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38206423)

  • 1. Development of a TLR-Based Model That Can Predict Prognosis, Tumor Microenvironment, and Drug Response for Esophageal Squamous Cell Carcinoma.
    Cheng T; Huang X; Yang H; Gu J; Lu C; Zhan C; Xu F; Ge D
    Biochem Genet; 2024 Jan; ():. PubMed ID: 38206423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
    Zhang M; Liang Y; Song P
    J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
    Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
    Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma.
    Cheng J; Chen F; Cheng Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.
    Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C
    J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
    Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y
    World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
    Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558
    [No Abstract]   [Full Text] [Related]  

  • 11. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing.
    Wang X; Peng W; Zhao Y; Sha J; Li N; Huang S; Wang H
    Front Oncol; 2024; 14():1370801. PubMed ID: 38903709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
    Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
    Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment.
    Cui Y; Hou R; Lv X; Wang F; Yu Z; Cui Y
    Front Oncol; 2021; 11():771749. PubMed ID: 34760708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
    Front Immunol; 2022; 13():918154. PubMed ID: 35880180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
    Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.